Summaries & Associations of Study Results
TR-318 Ampicillin Trihydrate
Target Organs and Levels of Evidence
NTP Technical Report Number 318
Produced from Chemtrack Database 09/19/01
| CHEMICAL/ CAS NUMBER | PEER REVIEW DATE | PRIMARY USES | ROUTE/EXPOSURE LEVELS | STUDY LABORATORY |
|---|---|---|---|---|
| AMPICILLIN TRIHYDRATE 7177-48-2 |
12/09/85 | ANTIBIOTIC, ANTIMICROBIAL | Gavage R: 0,750,1500, M: 0,1500,3000 MG/KG/50 PER GROUP | Springborn Inst. for Bioresearch, Inc. |
| LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM): | ||||
| MR: EQUIVOCAL EVIDENCE | ADRENAL GLAND MEDULLA: PHEOCHROMOCYTOMA 13/50 12/50 23/49 OR MALIGNANT PHEOCHROMOCYTOMA 1/50 5/50 1/49 COMBINED 13/50 16/50 23/49 | |||
| HEMATOPOIETIC SYSTEM: LEUKEMIA 5/50 14/50 13/50 | ||||
| NON-NEOPLASTIC LESIONS: | FORESTOMACH: HYPERKERATOSIS; ACANTHOSIS | |||
| FR: NO EVIDENCE | ||||
| MM: NO EVIDENCE | ||||
| NON-NEOPLASTIC LESIONS: | FORESTOMACH: ULCERS; INFLAMMATION; HYPERKERATOSIS; ACANTHOSIS | |||
| FM: NO EVIDENCE | ||||
Web page last updated on February 10, 2006
